Browsing by Author Tsai, CM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 2 to 5 of 5 < previous 
TitleAuthor(s)Issue DateViews
 
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
Journal:International Journal of Clinical Oncology
Chang, GCLam, DCLTsai, CMChen, YMShih, JYAggarwal, SWang, SKim, SWKim, YCWahid, ILi, RLim, DWTSriuranpong, VChan, RTTLorence, RMCarriere, PRaabe, CCseh, APark, K
2021
 
Impact of epidermal growth factor receptor inhibitor in non-small cell lung cancer on progression-free an overall survival: a meta-analysis
Journal:Journal of the National Cancer Institute
Lee, CHBrown, CGralla, RHirsh, VThongprasert, STsai, CMTan, EHHo, JCMChu, DTZaatar, ASanchez, JOVu, VVAu, JSKInoue, ALee, SMGebski, VYang, JCH
2013
68
 
Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin in East Asian patients with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC)
Proceeding/Conference:Journal of Clinical Oncology
Lu, SMok, TLu, YZhou, YShi, YKSriuranpong, VHo, JCMOng, CKTsai, CMChung, CHWilner, KDTang, YMasters, ESelaru, PWu, YL
2016
 
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer
Journal:Journal of Thoracic Oncology
Wu, YLLu, SLu, YZhou, JYShui, YKSriuranpong, VHo, JCMOng, CKTsai, CMChung, CHWilner, KDTang, YMasters, ETSelaru, PMok, TS
2018
60
Showing results 2 to 5 of 5 < previous